CAH Cardinal Health, Inc. Common Stock
Acerca de Cardinal Health, Inc. Common Stock Descripción general de la empresa de Wikipedia
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Leer más
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
History
Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. The company went public on the NASDAQ stock exchange in 1983.
In 1988, Walter sold Cardinal Health's food operations to Roundy's. From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States.
2000–2019
R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO.
In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. Cardinal Health is now traded on the NYSE under symbol CAH.
In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. The venture was named Red Oak Sourcing and began operations in July 2014.
Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016.
In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company.
Opioid lawsuits
In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. Cardinal will pay $6.4 billion over 18 years.
In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."
2020–present
As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. The firm employs 57,000 people worldwide.
Acquisitions
In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. The merger represented the first non-distribution acquisition by Cardinal Health.
In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million.
In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. Instead, Amerisource and Bergen merged into AmerisourceBergen. Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.
In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis.
In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare.
In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.
On March 18, 2013, Cardinal Health acquired the Twinsburg, Ohio-based privately held medical supply distributor AssuraMed, and with it its subsidiaries including Edgepark Medical Supplies, for $2.7 billion. AssuraMed was backed by private equity firms Clayton, Dubilier & Rice and Goldman Sachs Alternatives.
In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. The companies started buying generic drugs around the world to sell in U.S. markets.
In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. The acquisition was completed on October 4, 2015. Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.
In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. The acquisition was completed on July 30, 2017.
In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business. The at-Home Solutions business includes Edgepark Medical Supplies of Twinsburg, Ohio and United States Medical Supply (US MED) of Doral, Florida. The acquisition was complete by April 2024.
In August 2025, Cardinal Health announced that it would acquire a 75% stake in Solaris Health, the largest urology management services organization (MSO) in the United States, for $1.9 billion in cash.
In July 2026, Cardinal Health agreed to acquire AdaptHealth's diabetes health business and medical-supply provider Strive Medical in separate transactions worth approximately US$360 million in total. The acquisitions were intended to expand its at-Home Solutions business in diabetes and urological care.
Controversy
Role in the Opioid epidemic
Multiple legal settlements have demonstrated Cardinal Health's role in the US Opioid epidemic, though the company never admitted wrongdoing:
December 2016: Cardinal Health settled for $44 million for violations of the Controlled Substances Act brought in allegations from United States Attorneys in districts from Maryland, New York, Florida and Washington.
July 2021: Cardinal Health agreed to pay $6.4 billion to settle thousands of US lawsuits. They were one of four companies to pay $26 billion, including Johnson & Johnson, AmerisourceBergen and McKesson.
May 2022: Settled a derivative suit on behalf of shareholders for $124 million.
August 2024: Settlement with various health plans including insurers and third-party payers for $92.7 million.
August 2024: Settlement with the City of Baltimore for $152.5 million.
Restatements
In September 2004, Cardinal Health announced plans to restate past results for fiscal 2001, 2002, 2003, and the first three quarters of 2004 downward, after an accounting review and an ongoing federal investigation. In 2005, in connection with the Audit Committee's conclusions reached in September and October 2004, the company made certain reclassification and restatement adjustments to its fiscal 2004 and prior historical consolidated financial statements. According to The Wall Street Journal, "Analysts called the restatement decision troubling, yet limited in scope."
FDA action
In August 2006, Cardinal Health ceased production of its Alaris SE infusion pump after approximately 1300 units were seized by the United States Food and Drug Administration (FDA). In February 2007, Cardinal Health signed a consent decree with the FDA which promised procedures to guarantee the safety of the Alaris SE. After FDA inspections, Cardinal Health entered into a further consent agreement with the FDA in 2009.
DEA investigation into Oxycodone diversion
In 2008, Cardinal Health agreed to pay $34 million in civil penalties to settle DEA allegations that it failed to report suspicious orders of hydrocodone. The fine followed a 10-month DEA suspension of a Lakeland, Florida distribution facility and two others in New Jersey and Washington. On February 2, 2012, the Drug Enforcement Administration again suspended the license of the firm's Lakeland distribution center to distribute controlled substances on charges that it had allowed four Florida pharmacies to purchase excessive amounts of controlled substances, in particular oxycodone.
Cardinal Health obtained a restraining order against the suspension, but the suspension was upheld on February 29 by a Federal district court because the court agreed with the DEA that Cardinal Health's activities represented an "imminent danger to the public." The company stated that it blocked two of the pharmacies, (Brooks Pharmacy in Bonita Springs, Florida, and Gulf Coast Medical in Panama City, Florida), and notified the corporate owners of the two pharmacies that were part of national chains, two CVS stores in Sanford, Florida.
In February 2012, Joseph Rannazzisi, chief of the Drug Enforcement Administration’s Office of Diversion Control, issued immediate suspension orders against Cardinal's supply of oxycodone to suspected pill mills. These orders were filed after Deputy Attorney General James M. Cole met with Rannazzisi to ask if he had met with Cardinal about the investigation. Cole stated that he believed “it made good sense to listen to what Cardinal had to say” regarding the investigation. That year, Cardinal and the DEA reached a settlement that suspended Cardinal's facility in Lakeland, Florida from selling pain killers or other drugs for two years. In 2016, Cardinal was fined $44 million for after the investigation concluded.
In January 2022, Cardinal Health, Johnson & Johnson, McKesson, and AmerisourceBergen agreed to pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties.
Finances
Annual financial statistics are displayed below:
Cardinal Health Foundation
The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In 2008, the foundation established its E3 Grant Program. Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations.
Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
CAH Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
CAH Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto |
|---|---|
| 1 de julio de 2026 | $0,5160 |
| 1 de abril de 2026 | $0,5110 |
| 2 de enero de 2026 | $0,5110 |
| 1 de octubre de 2025 | $0,5110 |
| 1 de julio de 2025 | $0,5110 |
| 1 de abril de 2025 | $0,5060 |
| 2 de enero de 2025 | $0,5060 |
| 1 de octubre de 2024 | $0,5060 |
| 1 de julio de 2024 | $0,5060 |
| 28 de marzo de 2024 | $0,5010 |
| 29 de diciembre de 2023 | $0,5010 |
| 2 de octubre de 2023 | $0,5010 |
| 30 de junio de 2023 | $0,5010 |
| 31 de marzo de 2023 | $0,4960 |
| 30 de diciembre de 2022 | $0,4960 |
| 30 de septiembre de 2022 | $0,4960 |
| 30 de junio de 2022 | $0,4960 |
| 31 de marzo de 2022 | $0,4910 |
| 31 de diciembre de 2021 | $0,4910 |
| 30 de septiembre de 2021 | $0,4910 |
CAH Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 8 34,8%
- Compra 12 52,2%
- Mantener 3 13,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
15 analistas · 2026-08-14Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de diciembre de 2026 | $2.91 | $2.44 | 0.47% |
| 30 de junio de 2026 | $2.91 | $2.44 | 0.47% |
| 31 de marzo de 2026 | $3.17 | $2.82 | 0.35% |
| 31 de diciembre de 2025 | $2.63 | $2.40 | 0.23% |
| 30 de septiembre de 2025 | $2.55 | $2.20 | 0.35% |
| 30 de junio de 2025 | $2.08 | $2.06 | 0.02% |
| 31 de marzo de 2025 | $2.35 | $2.19 | 0.16% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Cost of Revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B | $115.00B | $96.82B | |
| Gross Profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B | $6.54B | $5.71B | |
| SG&A Expense | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.77B | $3.65B | $3.24B | |
| Operating Income | $2.61B | $2.27B | $1.24B | $752M | $-607M | $472M | $-4.10B | $2.06B | $126M | $2.12B | $2.46B | $2.16B | |
| Interest Expense | $348M | $215M | $51M | $84M | $147M | $180M | $238M | $294M | $329M | $201M | $178M | $141M | |
| Other Non-op | $31M | $41M | $9M | $-5M | $-22M | $47M | $1M | $-15M | $-23M | $5M | $-5M | $7M | |
| Pretax Income | $2.17B | $2.10B | $1.20B | $663M | $-784M | $323M | $-3.77B | $1.75B | $-228M | $1.92B | $2.28B | $1.97B | |
| Income Tax | $469M | $532M | $348M | $332M | $153M | $-289M | $-79M | $386M | $-487M | $630M | $845M | $755M | |
| Net Income | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| EPS (Basic) | $7.27 | $6.48 | $3.48 | $1.27 | $-3.37 | $2.09 | $-12.61 | $4.55 | $0.82 | $4.06 | $4.36 | $3.66 | |
| EPS (Diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 | |
| Shares (Basic) | 236,000,000 | 241,000,000 | 245,000,000 | 261,000,000 | 279,000,000 | 292,000,000 | 293,000,000 | 300,000,000 | 313,000,000 | 317,000,000 | 327,000,000 | 332,000,000 | |
| Shares (Diluted) | 237,000,000 | 242,000,000 | 247,000,000 | 262,000,000 | 279,000,000 | 294,000,000 | 293,000,000 | 301,000,000 | 315,000,000 | 320,000,000 | 330,000,000 | 335,000,000 | |
| EBITDA | $3.57B | $3.06B | $1.95B | $1.42B | $96M | $1.25B | $-3.19B | $3.06B | $1.16B | $2.84B | $3.10B | $2.61B |
Balance general 25
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B | $2.36B | $4.62B | |
| Short-term Investments | · | · | $200M | · | · | · | · | · | · | $65M | $113M | $91M | |
| Receivables | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B | $7.41B | $6.52B | |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B | $10.62B | $9.21B | |
| Other Current Assets | $2.76B | $2.41B | $2.66B | $2.29B | $2.02B | $2.84B | $1.71B | $1.95B | $1.93B | $2.12B | $1.58B | $1.40B | |
| Current Assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B | $21.96B | $21.75B | |
| PP&E (Net) | $3.03B | $2.86B | $2.53B | $2.46B | $2.36B | $2.36B | $2.37B | $2.36B | $2.49B | $1.88B | $1.80B | $1.51B | |
| PP&E (Gross) | $7.97B | $7.52B | $6.70B | $6.31B | $5.88B | $5.59B | $5.33B | $5.17B | $5.26B | $4.63B | $4.48B | $4.03B | |
| Accum. Depreciation | $4.93B | $4.66B | $4.17B | $3.85B | $3.52B | $3.23B | $2.96B | $2.81B | $2.77B | $2.75B | $2.68B | $2.53B | |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B | $7.17B | $5.07B | |
| Intangibles | $2.19B | $2.49B | $1.73B | $1.47B | $1.77B | $2.10B | $2.92B | $3.43B | $3.91B | $1.99B | $1.99B | $948M | |
| Other Non-current Assets | $1.88B | $1.71B | $1.26B | $1.07B | $953M | $951M | $1.19B | $1.05B | $682M | $681M | $944M | $866M | |
| Total Assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B | |
| Accounts Payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B | $23.70B | $21.37B | $21.54B | $19.68B | $17.91B | $17.31B | $14.37B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | $0 | |
| Current Liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.61B | $24.11B | $22.89B | $21.22B | $19.70B | $17.24B | |
| Capital Leases | $861M | $654M | $400M | $375M | $388M | $374M | $341M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $1.75B | $1.81B | $1.95B | $1.70B | $328M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | · | |
| Common Stock | $2.89B | $2.96B | $2.92B | $2.75B | $2.81B | $2.81B | $2.79B | $2.76B | $2.73B | $2.70B | $3.01B | $3.00B | |
| Retained Earnings | $2.01B | $783M | $-286M | $-642M | $-280M | $1.21B | $1.17B | $5.43B | $4.64B | $4.97B | $6.42B | $5.52B | |
| Treasury Stock | $7.61B | $6.37B | $5.68B | $4.91B | $3.13B | $2.19B | $2.07B | $1.79B | $1.22B | $731M | $2.76B | $2.25B | |
| AOCI | $-165M | $-155M | $-167M | $-151M | $-114M | $-34M | $-104M | $-79M | $-92M | $-125M | $-116M | $-23M | |
| Stockholders' Equity | $-2.88B | $-2.78B | $-3.21B | $-2.96B | $-709M | $1.79B | $1.79B | $6.33B | $6.06B | $6.81B | $6.55B | $6.26B | |
| Liabilities + Equity | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B |
Flujo de Efectivo 19
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $956M | $790M | $710M | $692M | $692M | $783M | $913M | $1.00B | $1.03B | $717M | $641M | $451M | |
| Stock-based Comp | $367M | $244M | $121M | $96M | $81M | $89M | $90M | $82M | $85M | $96M | $111M | $110M | |
| Deferred Tax | $91M | $243M | $-104M | $-40M | $14M | $496M | $-961M | $-83M | $-1.01B | $291M | $87M | $219M | |
| Amort. of Intangibles | $361M | $303M | $264M | $281M | $311M | $428M | $512M | $531M | $574M | $395M | $355M | $191M | |
| Restructuring | $106M | $88M | $175M | $95M | $101M | $114M | $122M | $125M | $176M | $56M | $25M | $44M | |
| Other Non-cash | $2.05B | $-441M | $2.18B | $1.82B | $3.27B | $450M | $5.61B | $360M | $2.41B | · | $705M | $545M | |
| Operating Cash Flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B | $2.97B | $2.54B | |
| CapEx | $649M | $547M | $511M | $481M | $387M | $400M | $375M | $328M | $384M | $387M | $465M | $300M | |
| Investing Cash Flow | $-2.58B | $-5.59B | $-1.85B | $-454M | $567M | $-378M | $493M | $338M | $-5.61B | $-405M | $-4.08B | $-849M | |
| Debt Issued | $1.00B | $2.90B | $1.14B | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $347M | $2.46B | $357M | $-579M | $-885M | $-570M | $-1.40B | $-1.10B | $-954M | $-310M | $-6M | $-1.22B | |
| Stock Repurchased | $1.36B | $765M | $750M | $2.00B | $1.00B | $200M | $350M | $600M | $550M | $600M | $651M | $1.04B | |
| Net Stock Activity | $-1.36B | $-765M | $-750M | $-2.00B | $-1.00B | $-200M | $-350M | $-600M | $-550M | $-600M | $-651M | $-1.04B | |
| Dividends Paid | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M | |
| Financing Cash Flow | $-1.60B | $1.94B | $-847M | $-3.05B | $-2.46B | $-1.32B | $-2.20B | $-2.29B | $-2.28B | $3.75B | $-1.14B | $60M | |
| Net Change in Cash | $982M | $-1.26B | $1.06B | $-669M | $1.36B | $636M | $240M | $768M | $-5.12B | $4.52B | $-2.26B | $1.75B | |
| Taxes Paid | $338M | $444M | $191M | $156M | $-766M | $273M | $368M | $311M | $425M | $686M | $635M | $529M | |
| Free Cash Flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B | $2.03B | $1.58B | $2.39B | $2.38B | $797M | $2.51B | $2.24B | |
| Levered FCF | $4.25B | $1.69B | $3.21B | $2.32B | $2.55B | $1.69B | $1.35B | $2.16B | $2.76B | $662M | $2.39B | $2.15B |
Rentabilidad 8
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% | 5.6% | |
| Operating Margin | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% | 0.29% | -2.7% | 1.4% | 0.09% | 1.6% | 2.0% | 2.1% | |
| Net Margin | 0.67% | 0.70% | 0.38% | 0.13% | -0.51% | 0.38% | -2.4% | 0.94% | 0.19% | · | 1.2% | 1.2% | |
| Pretax Margin | 0.86% | 0.94% | 0.53% | 0.31% | -0.42% | 0.20% | -2.5% | 1.2% | -0.17% | 1.5% | 1.9% | 1.9% | |
| EBITDA Margin | 1.4% | 1.4% | 0.86% | 0.69% | 0.05% | 0.77% | -2.1% | 2.1% | 0.85% | 2.2% | 2.5% | 2.5% | |
| ROA | 3.1% | 3.2% | 1.9% | 0.60% | -2.1% | 1.4% | -9.0% | 3.4% | 0.64% | · | 4.4% | 4.3% | |
| ROE | -60.5% | -52.1% | -27.6% | -14.7% | -172.5% | 34.1% | -91.1% | 22.0% | 4.0% | · | 22.3% | 19.2% | |
| ROIC | -71.1% | -61.1% | -27.5% | -10.5% | 101.9% | 49.9% | -224.3% | 25.4% | -2.4% | 18.6% | 23.6% | 21.3% |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.3 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | · | |
| Interest Coverage | 7.5 | 10.6 | 24.4 | 7.8 | -4.0 | 2.6 | -17.2 | 7.0 | 0.4 | 10.5 | 13.8 | 15.3 |
Eficiencia 3
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.6 | 4.5 | 5.1 | 4.7 | 4.1 | 3.8 | 3.7 | 3.6 | 3.4 | 3.5 | 3.8 | 3.7 | |
| Inventory Turnover | 14.3 | 13.5 | 14.1 | 12.5 | 11.6 | 11.2 | 11.2 | 11.0 | 11.0 | 11.3 | 11.6 | 11.1 | |
| Receivables Turnover | 18.8 | 17.6 | 19.6 | 18.7 | 18.4 | 18.7 | 18.3 | 17.9 | 17.3 | 16.8 | 17.5 | 17.2 |
Tasas de Crecimiento 10
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.4% | 7.1% | 11.8% | 10.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.4% | 7.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 12.1% | 87.0% | 173.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 79.0% | · | 18.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 28.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 9.8% | 83.2% | 158.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 73.2% | · | 11.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 22.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -3.0% | -2.8% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 6
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Net Income TTM | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| P/E | 32.9 | 26.0 | 28.5 | 75.1 | -15.5 | 27.4 | -4.1 | 10.4 | 60.3 | 19.3 | 18.1 | 23.1 | |
| Earnings Yield | 3.0% | 3.8% | 3.5% | 1.3% | -6.5% | 3.6% | -24.2% | 9.6% | 1.7% | 5.2% | 5.5% | 4.3% | |
| Payout Ratio | 28.6% | 31.6% | 58.6% | 201.1% | -59.9% | 93.8% | -15.4% | 42.3% | 226.9% | · | 35.9% | 37.9% | |
| Annual Payout | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M |
Estado de resultados 15
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B | $53.42B | $50.50B | $51.47B | $49.59B | |
| Cost of Revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B | $57.98B | $52.93B | $55.59B | $52.91B | $51.61B | $48.69B | $49.78B | $48.00B | |
| Gross Profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B | $1.81B | $1.81B | $1.68B | $1.60B | |
| SG&A Expense | $1.62B | $1.54B | $1.50B | $1.46B | $1.48B | $1.31B | $1.31B | $1.28B | $1.28B | $1.27B | $1.27B | $1.19B | $1.23B | $1.17B | $1.18B | $1.20B | |
| Operating Income | $729M | $509M | $707M | $668M | $428M | $730M | $549M | $568M | $401M | $369M | $505M | $-32M | $162M | $604M | $-86M | $123M | |
| Interest Expense | · | · | $88M | $80M | $74M | $74M | $35M | $32M | $9M | $28M | $3M | $11M | $6M | $26M | $24M | $24M | |
| Other Non-op | $26M | $-16M | $11M | $10M | $30M | $9M | $-3M | $5M | $-1M | $1M | $10M | $-1M | $-10M | $-2M | $6M | $-3M | |
| Pretax Income | $554M | $392M | $630M | $598M | $384M | $665M | $511M | $541M | $391M | $342M | $512M | $-44M | $146M | $576M | $-104M | $96M | |
| Income Tax | $154M | $12M | $159M | $144M | $141M | $157M | $110M | $124M | $158M | $80M | $143M | $-33M | $143M | $209M | $-27M | $-3M | |
| Net Income | $398M | $399M | $467M | $450M | $239M | $506M | $400M | $416M | $235M | $261M | $368M | $-12M | $5M | $365M | $-77M | $98M | |
| EPS (Basic) | · | · | · | $1.89 | · | · | · | $1.71 | · | $1.07 | $1.50 | $-0.05 | · | $1.43 | $-0.30 | $0.36 | |
| EPS (Diluted) | · | · | · | $1.88 | · | · | · | $1.70 | · | $1.07 | $1.50 | $-0.05 | · | $1.41 | $-0.30 | $0.36 | |
| Shares (Basic) | -473,000,000 | 235,000,000 | 236,000,000 | 238,000,000 | -484,000,000 | 240,000,000 | 242,000,000 | 243,000,000 | -492,000,000 | 243,000,000 | 245,000,000 | 249,000,000 | -527,000,000 | 256,000,000 | 261,000,000 | 271,000,000 | |
| Shares (Diluted) | -475,000,000 | 236,000,000 | 237,000,000 | 239,000,000 | -487,000,000 | 241,000,000 | 243,000,000 | 245,000,000 | -493,000,000 | 245,000,000 | 246,000,000 | 249,000,000 | -530,000,000 | 258,000,000 | 261,000,000 | 273,000,000 | |
| EBITDA | · | $757M | $941M | $901M | · | $730M | $549M | $750M | · | $367M | $482M | $158M | · | $572M | $-119M | $308M |
Balance general 21
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.72B | $4.59B | $3.85B | · | $3.99B | $3.65B | $3.49B | |
| Receivables | $13.81B | $13.65B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B | $11.57B | $11.79B | $11.27B | · | $10.99B | $11.42B | $11.04B | |
| Inventory | $17.30B | $18.01B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B | $17.28B | $18.45B | $16.99B | · | $16.62B | $17.26B | $15.89B | |
| Other Current Assets | $2.76B | $2.47B | $2.67B | $2.60B | $2.41B | $2.40B | $2.62B | $2.59B | $2.66B | $3.16B | $2.82B | $2.58B | · | $1.90B | $2.26B | $2.27B | |
| Current Assets | $38.75B | $38.06B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B | $35.73B | $37.66B | $34.69B | · | $33.50B | $34.60B | $32.70B | |
| PP&E (Net) | $3.03B | $2.93B | $2.88B | $2.83B | $2.86B | $2.66B | $2.56B | $2.54B | $2.53B | $2.47B | $2.45B | $2.44B | · | $2.36B | $2.34B | $2.34B | |
| PP&E (Gross) | $7.97B | · | · | · | $7.52B | · | · | · | $6.70B | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.93B | · | · | · | $4.66B | · | · | · | $4.17B | · | · | · | · | · | · | · | |
| Goodwill | $11.44B | $11.41B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B | $4.79B | $4.02B | $4.03B | $4.61B | $5.00B | $4.99B | $5.67B | |
| Intangibles | $2.19B | $2.28B | $2.37B | $2.40B | $2.49B | $2.11B | $1.95B | $1.66B | $1.73B | $1.72B | $1.35B | $1.41B | · | $1.57B | $1.63B | $1.69B | |
| Other Non-current Assets | $1.88B | $2.00B | $2.00B | $1.75B | $1.71B | $1.60B | $1.25B | $1.23B | $1.26B | $1.17B | $1.10B | $1.15B | · | $951M | $927M | $985M | |
| Total Assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B | |
| Accounts Payable | $38.28B | $37.83B | $39.00B | $36.86B | $34.71B | $32.81B | $31.30B | $30.36B | $31.76B | $32.09B | $34.26B | $31.54B | · | $29.60B | $30.08B | $28.36B | |
| Current Liabilities | $43.90B | $41.99B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B | $36.31B | $38.29B | $35.06B | · | $32.50B | $33.21B | $31.56B | |
| Capital Leases | $861M | · | · | · | $654M | · | · | · | $400M | · | · | · | · | · | · | · | |
| Common Stock | $2.89B | $2.81B | $2.85B | $2.75B | $2.96B | $2.95B | $2.93B | $2.83B | $2.92B | $2.89B | $2.85B | $2.73B | · | $2.82B | $2.75B | $2.58B | |
| Retained Earnings | $2.01B | $1.73B | $1.46B | $1.12B | $783M | $664M | $283M | $14M | $-286M | $-289M | $-425M | $-654M | · | $-342M | $-560M | $-301M | |
| Treasury Stock | $7.61B | $7.22B | $7.03B | $6.58B | $6.37B | $6.38B | $6.03B | $5.96B | $5.68B | $5.70B | $5.72B | $5.40B | $4.91B | $4.55B | $4.25B | $3.88B | |
| AOCI | $-165M | $-161M | $-153M | $-159M | $-155M | $-176M | $-180M | $-155M | $-167M | $-160M | $-155M | $-165M | · | $-142M | $-146M | $-176M | |
| Stockholders' Equity | $-2.88B | $-2.83B | $-2.88B | $-2.88B | $-2.78B | $-2.95B | $-2.99B | $-3.28B | $-3.21B | $-3.27B | $-3.45B | $-3.49B | · | $-2.22B | $-2.21B | $-1.78B | |
| Liabilities + Equity | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B |
Flujo de Efectivo 17
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $241M | $248M | $234M | $233M | $209M | $207M | $192M | $182M | $186M | $177M | $175M | $172M | $176M | $175M | $170M | $171M | |
| Stock-based Comp | $58M | $129M | $87M | $93M | $153M | $31M | $30M | $30M | $33M | $31M | $28M | $29M | $27M | $21M | $25M | $23M | |
| Amort. of Intangibles | $95M | $95M | $84M | $87M | $89M | $77M | $69M | $68M | $73M | $64M | $63M | $64M | $70M | $69M | $71M | $71M | |
| Restructuring | $40M | $25M | $21M | $20M | $27M | $28M | $9M | $24M | $69M | $53M | $28M | $25M | $33M | $16M | $17M | $29M | |
| Other Non-cash | · | · | · | $197M | · | · | · | $-2.27B | · | · | · | $339M | · | · | · | $-281M | |
| Operating Cash Flow | $1.69B | $1.82B | $686M | $973M | $1.52B | $2.92B | $-396M | $-1.65B | $2.08B | $-54M | $1.16B | $528M | $863M | $1.36B | $597M | $23M | |
| CapEx | $264M | $146M | $131M | $108M | $232M | $126M | $99M | $90M | $193M | $112M | $114M | $92M | $217M | $109M | $85M | $70M | |
| Investing Cash Flow | $-281M | $-181M | $-1.98B | $-142M | $-1.63B | $-2.90B | $-976M | $-88M | $166M | $-1.85B | $-105M | $-63M | $-206M | $-91M | $-87M | $-70M | |
| Debt Issued | $0 | $0 | $0 | $1.00B | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $488M | · | · | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | |
| Stock Repurchased | $350M | $250M | $383M | $375M | $0 | $375M | $15M | $375M | $0 | $0 | $250M | $500M | $500M | $250M | $250M | $1.00B | |
| Net Stock Activity | · | · | · | $-375M | · | · | · | $-375M | · | · | · | $-500M | · | · | · | $-1.00B | |
| Dividends Paid | $120M | $120M | $122M | $129M | $120M | $124M | $122M | $128M | $122M | $122M | $124M | $131M | $126M | $128M | $129M | $142M | |
| Financing Cash Flow | $-490M | $-483M | $-519M | $-110M | $663M | $-507M | $2.33B | $-540M | $-859M | $1.03B | $-353M | $-666M | $-592M | $-934M | $-362M | $-1.16B | |
| Net Change in Cash | $919M | $1.16B | $-1.82B | $719M | $548M | $-484M | $943M | $-2.27B | $1.39B | $-878M | $710M | $-206M | $58M | $336M | $162M | $-1.23B | |
| Free Cash Flow | · | · | · | $865M | · | · | · | $-1.74B | · | · | · | $453M | · | · | · | $-47M | |
| Levered FCF | · | · | · | $804M | · | · | · | $-1.76B | · | · | · | $456M | · | · | · | $-72M |
Rentabilidad 8
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 4.1% | 3.6% | 3.6% | · | 3.9% | 3.5% | 3.6% | · | 3.5% | 3.2% | 3.2% | · | 3.5% | 3.2% | 3.2% | |
| Operating Margin | · | 0.84% | 1.1% | 1.0% | · | 1.3% | 0.99% | 1.1% | · | 0.67% | 0.84% | -0.03% | · | 1.1% | -0.23% | 0.28% | |
| Net Margin | · | 0.65% | 0.71% | 0.70% | · | 0.92% | 0.72% | 0.80% | · | 0.47% | 0.61% | 0.01% | · | 0.68% | -0.25% | 0.22% | |
| Pretax Margin | · | 0.64% | 0.96% | 0.93% | · | 1.2% | 0.92% | 1.0% | · | 0.62% | 0.85% | -0.05% | · | 1.1% | -0.27% | 0.22% | |
| EBITDA Margin | · | 1.2% | 1.4% | 1.4% | · | 1.3% | 0.99% | 1.4% | · | 0.67% | 0.84% | 0.29% | · | 1.1% | -0.23% | 0.62% | |
| ROA | · | 0.75% | 0.89% | 0.92% | · | 1.1% | 0.85% | 0.96% | · | 0.58% | 0.78% | 0.01% | · | 0.81% | -0.29% | 0.25% | |
| ROE | · | -13.8% | -15.9% | -14.6% | · | -16.3% | -12.4% | -12.3% | · | -9.4% | -12.5% | -0.19% | · | -23.6% | 21.4% | -56.7% | |
| ROIC | · | -17.4% | -18.3% | -17.6% | · | -18.9% | -14.4% | -13.4% | · | -8.5% | -10.1% | -0.09% | · | -16.4% | 5.1% | -7.8% |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.9 | 0.9 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | · | 0.4 | 0.4 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | 8.0 | 8.3 | · | 9.9 | 15.7 | 17.8 | · | 11.1 | 60.2 | -1.0 | · | 20.4 | -4.8 | 5.5 |
Eficiencia 3
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.3 | · | 1.1 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | · | 3.4 | 3.4 | 3.7 | · | 3.2 | 3.0 | 3.1 | · | 3.1 | 3.1 | 3.2 | · | 3.0 | 3.1 | 3.1 | |
| Receivables Turnover | · | 4.6 | 5.0 | 5.0 | · | 4.5 | 4.6 | 4.5 | · | 4.9 | 5.0 | 4.9 | · | 4.8 | 4.9 | 4.9 |
Valoración (TTM) 5
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $245.45B | $239.78B | $226.43B | · | $217.29B | $219.85B | $219.24B | · | $217.46B | $214.06B | $206.21B | · | $196.39B | $191.35B | $183.85B | |
| Net Income TTM | · | $1.82B | $1.82B | $1.77B | · | $1.58B | $1.45B | $1.03B | · | $982M | $644M | $374M | · | $-1.00B | $-1.32B | $-973M | |
| P/E | · | · | · | · | · | 32.6 | 28.0 | 26.2 | · | 28.5 | 39.4 | 61.1 | · | · | · | · | |
| Earnings Yield | · | · | · | · | · | 3.1% | 3.6% | 3.8% | · | 3.5% | 2.5% | 1.6% | · | · | · | · | |
| Payout Ratio | · | · | · | 28.7% | · | · | · | 30.8% | · | · | · | 2620.0% | · | · | · | 129.1% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Ingresos | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| Margen Bruto % | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% |
| Margen Operativo % | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% |
| Beneficio neto | $1.71B | $1.56B | $852M | $330M | $-938M |
| EPS Diluido | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
Balance general
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Ratio corriente | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 |
| Ratio Rápido | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 |
Flujo de Efectivo
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 1 625 declarantes · $31.0B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 162 (-12 vs trimestre anterior) | 80 (-20 vs trimestre anterior) | 516 (-30 vs trimestre anterior) | 545 (+38 vs trimestre anterior) | +35.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3 632 811 706 | 15 292 186 | 11,72% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 258 822 899 | 13 717 894 | 10,51% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $3 254 296 668 | 13 698 841 | 10,50% | Acciones |
| STATE STREET CORP | $2 842 909 265 | 11 967 121 | 9,17% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 350 305 229 | 5 709 017 | 4,35% | Acciones |
| WCM INVESTMENT MANAGEMENT, LLC | $971 445 537 | 4 112 461 | 3,13% | Acciones |
| NORGES BANK | $885 248 810 | 3 726 422 | 2,85% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $499 624 076 | 2 103 149 | 1,61% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $469 793 667 | 1 977 579 | 1,52% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $315 702 986 | 1 328 940 | 1,02% | Acciones |
| VANGUARD GROUP INC | $277 003 725 | 1 347 950 | 0,89% | Acciones |
| Robeco Institutional Asset Management B.V. | $258 918 781 | 1 089 909 | 0,84% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $244 584 818 | 1 029 571 | 0,79% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $230 523 823 | 970 390 | 0,74% | Acciones |
| BlackRock, Inc. | $225 912 433 | 950 970 | 0,73% | Acciones |
| Man Group plc | $220 862 620 | 929 713 | 0,71% | Acciones |
| FMR LLC | $211 855 495 | 891 798 | 0,68% | Acciones |
| GOLDMAN SACHS GROUP INC | $199 229 035 | 838 647 | 0,64% | Acciones |
| ProShare Advisors LLC | $197 187 154 | 830 052 | 0,64% | Acciones |
| NORDEA INVESTMENT MANAGEMENT AB | $192 568 890 | 809 283 | 0,62% | Acciones |
| Legal & General Group Plc | $184 918 605 | 778 408 | 0,60% | Acciones |
| JANE STREET GROUP, LLC | $169 712 864 | 714 400 | 0,55% | Opción de compra |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $160 043 538 | 677 519 | 0,52% | Acciones |
| Swiss National Bank | $157 644 816 | 663 600 | 0,51% | Acciones |
| JANE STREET GROUP, LLC | $153 701 320 | 647 000 | 0,50% | Opción de venta |
| Mitsubishi UFJ Asset Management Co., Ltd. | $141 722 832 | 596 577 | 0,46% | Acciones |
| 1832 Asset Management L.P. | $139 039 117 | 585 280 | 0,45% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $132 703 867 | 558 612 | 0,43% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $130 681 756 | 550 100 | 0,42% | Acciones |
| BANK OF AMERICA CORP /DE/ | $126 454 568 | 532 306 | 0,41% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $123 081 499 | 518 107 | 0,40% | Acciones |
| Vanguard Global Advisers, LLC | $122 136 010 | 514 127 | 0,39% | Acciones |
| LPL Financial LLC | $120 559 117 | 507 489 | 0,39% | Acciones |
| RHUMBLINE ADVISERS | $116 899 342 | 492 084 | 0,38% | Acciones |
| UBS Group AG | $116 739 360 | 491 410 | 0,38% | Acciones |
| National Pension Service | $113 432 762 | 477 491 | 0,37% | Acciones |
| FRED ALGER MANAGEMENT, LLC | $111 665 316 | 470 051 | 0,36% | Acciones |
| SEI INVESTMENTS CO | $110 593 700 | 465 540 | 0,36% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $109 533 215 | 461 076 | 0,35% | Acciones |
| BARCLAYS PLC | $108 067 946 | 454 908 | 0,35% | Acciones |
| LAZARD ASSET MANAGEMENT LLC | $106 528 318 | 448 427 | 0,34% | Acciones |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $104 481 026 | 439 809 | 0,34% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104 081 450 | 438 127 | 0,34% | Acciones |
| California Public Employees Retirement System | $103 583 999 | 436 033 | 0,33% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101 984 508 | 429 300 | 0,33% | Opción de compra |
| TWO SIGMA ADVISERS, LP | $96 441 150 | 469 300 | 0,31% | Acciones |
| JANUS HENDERSON GROUP PLC | $96 030 102 | 454 526 | 0,31% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $95 040 000 | 400 069 | 0,31% | Acciones |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $94 526 074 | 397 904 | 0,30% | Acciones |
| ING GROEP NV | $90 805 885 | 382 244 | 0,29% | Acciones |
| Retirement Systems of Alabama | $89 453 931 | 376 553 | 0,29% | Acciones |
| BANK OF NOVA SCOTIA | $88 870 008 | 374 095 | 0,29% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $88 654 749 | 373 189 | 0,29% | Acciones |
| Artemis Investment Management LLP | $87 745 162 | 369 360 | 0,28% | Acciones |
| TD Asset Management Inc | $85 393 555 | 359 461 | 0,28% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85 236 528 | 358 800 | 0,27% | Opción de venta |
| Delta Accumulation, LLC | $81 886 932 | 344 700 | 0,26% | Opción de venta |
| STOREBRAND ASSET MANAGEMENT AS | $80 500 769 | 338 865 | 0,26% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $79 269 258 | 333 681 | 0,26% | Acciones |
| ROYAL BANK OF CANADA | $79 026 000 | 332 656 | 0,25% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $78 334 941 | 370 711 | 0,25% | Acciones |
| Ensign Peak Advisors, Inc | $78 327 333 | 329 716 | 0,25% | Acciones |
| GFS Advisors, LLC | $76 777 103 | 55 | 0,25% | Acciones |
| Integral Health Asset Management, LLC | $71 268 000 | 300 000 | 0,23% | Acciones |
| Focus Partners Wealth | $69 563 786 | 292 826 | 0,22% | Acciones |
| ZACKS INVESTMENT MANAGEMENT | $69 526 717 | 292 669 | 0,22% | Acciones |
| PRUDENTIAL FINANCIAL INC | $69 141 838 | 291 050 | 0,22% | Acciones |
| FIRST TRUST ADVISORS LP | $63 253 014 | 266 262 | 0,20% | Acciones |
| Caisse de depot et placement du Quebec | $63 072 655 | 265 502 | 0,20% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $60 514 609 | 254 734 | 0,20% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $60 313 158 | 253 886 | 0,19% | Acciones |
| Gotham Asset Management, LLC | $59 744 915 | 251 494 | 0,19% | Acciones |
| NATIXIS | $57 996 711 | 244 135 | 0,19% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57 683 884 | 243 678 | 0,19% | Acciones |
| AMERIPRISE FINANCIAL INC | $56 823 880 | 239 198 | 0,18% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56 038 504 | 235 892 | 0,18% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $55 998 840 | 265 008 | 0,18% | Acciones |
| Vest Financial, LLC | $55 494 016 | 233 600 | 0,18% | Acciones |
| AVIVA PLC | $54 653 054 | 230 060 | 0,18% | Acciones |
| COOKSON PEIRCE & CO INC | $54 112 422 | 227 784 | 0,17% | Acciones |
| APG Asset Management N.V. | $52 132 088 | 250 895 | 0,17% | Acciones |
| Delta Accumulation, LLC | $50 101 404 | 210 900 | 0,16% | Opción de compra |
| Quantinno Capital Management LP | $49 716 731 | 209 280 | 0,16% | Acciones |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $48 954 227 | 206 071 | 0,16% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $48 870 606 | 205 719 | 0,16% | Acciones |
| Zurich Insurance Group Ltd/FI | $47 315 063 | 199 171 | 0,15% | Acciones |
| CRAWFORD INVESTMENT COUNSEL INC | $45 812 739 | 192 847 | 0,15% | Acciones |
| Cetera Investment Advisers | $45 437 576 | 191 268 | 0,15% | Acciones |
| Empyrean Capital Partners, LP | $43 758 552 | 184 200 | 0,14% | Acciones |
| Squarepoint Ops LLC | $43 560 427 | 183 366 | 0,14% | Acciones |
| PFA Pension, Forsikringsaktieselskab | $43 480 161 | 183 028 | 0,14% | Acciones |
| Davidson Kempner Capital Management LP | $43 260 389 | 182 103 | 0,14% | Acciones |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $42 795 484 | 180 146 | 0,14% | Acciones |
| Pictet Asset Management Holding SA | $42 685 837 | 179 688 | 0,14% | Acciones |
| OSAIC HOLDINGS, INC. | $41 443 725 | 174 339 | 0,13% | Acciones |
| CHURCHILL MANAGEMENT Corp | $40 806 561 | 242 896 | 0,13% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $40 701 876 | 171 074 | 0,13% | Acciones |
| AMF Tjanstepension AB | $40 543 890 | 170 668 | 0,13% | Acciones |
| Voleon Capital Management LP | $40 128 160 | 168 918 | 0,13% | Acciones |
| CITADEL ADVISORS LLC | $40 028 860 | 168 500 | 0,13% | Opción de compra |
Informantes de la empresa 85 insiders · 45 directivos · 37 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Deborah Weitzman | CEO, PSS Segment | 15 de agosto de 2026 F | 85 255 | 0 | 1 | $-3 216 375 |
| Stephen M Mason | CEO, GMPD Segment | 15 de agosto de 2026 F | 53 061 | 0 | 3 | $-6 187 063 |
| Jason M. Hollar | Chief Executive Officer | 15 de agosto de 2026 F | 315 132 | 0 | 5 | $-21 424 216 |
| Michael C Kaufmann | CEO | 15 de agosto de 2022 M | 601 065 | 0 | 0 | $0 |
| Victor L. Crawford | CEO, Pharmaceutical Segment | 15 de agosto de 2022 F | 105 699 | 0 | 0 | $0 |
| Jon L Giacomin | CEO, Medical Segment | 15 de agosto de 2019 F | 61 387 | 0 | 0 | $0 |
| Donald M Casey Jr. | CEO, Medical Segment | 15 de septiembre de 2017 F | 146 503 | 0 | 0 | $0 |
| Michael A Lynch | CEO, Medical Segment | 27 de febrero de 2012 M | 89 204 | 0 | 0 | $0 |
| Kerry R Clark | Former Chairman and CEO | 1 de septiembre de 2009 A | 238 635 | 0 | 0 | $0 |
| Mark W Parrish | CEO - HSCS | 2 de septiembre de 2007 F | 68 041 | 0 | 0 | $0 |
| Ronald K Labrum | CEO-Supply Chain Svcs. | 16 de mayo de 2006 M | 36 082 | 0 | 0 | $0 |
| Joseph C Papa | Chmn & CEO, Pharm Techn & Svcs | 13 de diciembre de 2004 A | 14 400 | 0 | 0 | $0 |
| Aaron E Alt | Chief Financial Officer | 15 de agosto de 2026 F | 62 495 | 0 | 2 | $-7 177 390 |
| Jorge M Gomez | Chief Financial Officer | 8 de noviembre de 2018 F | 39 582 | 0 | 0 | $0 |
| Jeffrey William Henderson | Chief Financial Officer | 27 de agosto de 2014 M | 67 190 | 0 | 0 | $0 |
| Richard J Miller | EVP & CFO | 17 de noviembre de 2003 A | — | 0 | 0 | $0 |
| George L Fotiades | President & COO | 15 de enero de 2003 P | 80 278 | 0 | 0 | $0 |
| Valerie Christine Pitteroff | Chief Human Resources Officer | 15 de agosto de 2026 F | 11 757 | 0 | 0 | $0 |
| Mary C. Scherer | Chief Accounting Officer | 15 de agosto de 2026 F | 5 113 | 0 | 1 | $-1 009 826 |
| Michelle D. Greene | Chief Information Officer | 15 de agosto de 2026 F | 21 980 | 0 | 2 | $-2 009 043 |
| Jessica L Mayer | Chief Legal/Compliance Officer | 15 de agosto de 2026 F | 62 512 | 0 | 3 | $-5 666 833 |
| Ola M Snow | Chief Human Resources Officer | 19 de agosto de 2025 S | 15 431 | 0 | 2 | $-4 192 917 |
| Patricia M English | Chief Accounting Officer | 15 de agosto de 2022 F | 9 000 | 0 | 0 | $0 |
| Brian S Rice | Chief Information Officer | 15 de agosto de 2022 F | 37 850 | 0 | 0 | $0 |
| Michele Holcomb | EVP - Strategy & Corp. Dev. | 15 de agosto de 2022 F | 44 491 | 0 | 0 | $0 |
| Stuart G Laws | SVP & Chief Accounting Officer | 15 de agosto de 2020 F | 12 289 | 0 | 0 | $0 |
| Craig S Morford | Chief Legal/Compliance Officer | 3 de diciembre de 2018 F | 126 301 | 0 | 0 | $0 |
| Patricia Morrison | Chief Information Officer | 31 de agosto de 2018 F | 30 725 | 0 | 0 | $0 |
| Pamela O. Kimmet | Chief Human Resources Officer | 15 de agosto de 2018 F | 22 612 | 0 | 0 | $0 |
| George S Barrett | Executive Chairman | 15 de agosto de 2018 F | 502 630 | 0 | 0 | $0 |
| Carole S Watkins | Chief HR Officer | 20 de mayo de 2016 M | 31 585 | 0 | 0 | $0 |
| Falk T Stephen | EVP, Gen. Counsel & Corp. Sec. | 30 de noviembre de 2015 G | 32 455 | 0 | 0 | $0 |
| Meghan Fitzgerald | EVP, Strategy & Health Policy | 17 de noviembre de 2015 F | 16 760 | 0 | 0 | $0 |
| Mark R Blake | EVP - Strategy & Corp. Dev. | 7 de noviembre de 2014 M | 20 409 | 0 | 0 | $0 |
| Ivan K Fong | CLO & Secretary | 1 de noviembre de 2008 F | 50 886 | 0 | 0 | $0 |
| Vivek Jain | EVP - Corp. Dev. & Strategy | 26 de septiembre de 2008 A | 39 594 | 0 | 0 | $0 |
| Daniel J Walsh | EVP, Chf Ethcs & Compl Offcr | 26 de noviembre de 2007 I | 1 740 | 0 | 0 | $0 |
| Eric Slusser | EVP, CAO & Controller | 4 de junio de 2007 M | 8 573 | 0 | 0 | $0 |
| Brendan A Ford | EVP-Corporate Development | 2 de septiembre de 2006 F | 85 978 | 0 | 0 | $0 |
| RUCCI ANTHONY J | EVP & Chief Admin. Officer | 6 de septiembre de 2005 G | 55 382 | 0 | 0 | $0 |
| Gary D Dolch | EVP - Quality & Reg. Affairs | 2 de septiembre de 2005 A | 6 137 | 0 | 0 | $0 |
| Jody R Davids | EVP & CIO | 2 de septiembre de 2005 A | 4 607 | 0 | 0 | $0 |
| Paul S Williams | EVP, CLO & Secretary | 17 de febrero de 2005 G | 7 000 | 0 | 0 | $0 |
| Gary S Jensen | SVP - Corporate Controller | 23 de agosto de 2004 A | 2 462 | 0 | 0 | $0 |
| Stephen S Thomas | EVP-Group Pres.-AIS | 24 de febrero de 2004 M | 31 039 | 0 | 0 | $0 |
| Hall Patricia Hemingway | Consejero | 15 de abril de 2026 A | 28 645 | 0 | 0 | $0 |
| Christine Mundkur | Consejero | 5 de noviembre de 2025 A | 7 536 | 0 | 0 | $0 |
| Gregory B Kenny | Consejero | 5 de noviembre de 2025 A | 64 194 | 0 | 0 | $0 |
| Sudhakar Ramakrishna | Consejero | 15 de marzo de 2025 A | 1 049 | 0 | 0 | $0 |
| Michelle Brennan | Consejero | 6 de noviembre de 2024 A | 7 019 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Cardinal Health, Inc. ×2 presentaciones | 5 de junio de 2014 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 2 de julio de 2004 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 28 de mayo de 2004 | — | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 224 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| EGGS · Tidal Trust III | 4,07% | 11 627 NS | 31 de mayo de 2026 | N-PORT |
| BCUS · Exchange Listed Funds Trust | 2,96% | 16 250 NS | 31 de mayo de 2026 | N-PORT |
| IYK · iShares Trust | 2,53% | 151 717 SH | 8 de agosto de 2026 | Diario |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,21% | 17 153 SH | 8 de agosto de 2026 | Diario |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,98% | 89 549 NS | 30 de abril de 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 1,83% | 40 961 NS | 30 de abril de 2026 | N-PORT |
| FLOW · Global X Funds | 1,70% | 2 476 NS | 31 de mayo de 2026 | N-PORT |
| ZECP · Zacks Trust | 1,69% | 29 490 NS | 31 de mayo de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,66% | 54 825 SH | 8 de agosto de 2026 | Diario |
| COWZ · Pacer Funds Trust | 1,62% | 1 528 597 NS | 30 de abril de 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,62% | 3 926 NS | 30 de abril de 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,56% | 118 283 SH | 8 de agosto de 2026 | Diario |
| NOBL · ProShares Trust | 1,41% | 791 661 NS | 31 de mayo de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,38% | 796 NS | 30 de abril de 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,37% | 239 259 NS | 30 de abril de 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 1,34% | 23 570 SH | 8 de agosto de 2026 | Diario |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,34% | 563 995 SH | 8 de agosto de 2026 | Diario |
| GROZ · Zacks Trust | 1,19% | 5 456 NS | 31 de mayo de 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,09% | 10 932 NS | 30 de abril de 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,08% | 5 969 SH | 8 de agosto de 2026 | Diario |
| RPV · Invesco Exchange-Traded Fund Trust | 1,08% | 77 480 SH | 8 de agosto de 2026 | Diario |
| ESMV · iShares Trust | 1,06% | 350 SH | 8 de agosto de 2026 | Diario |
| NULV · Nushares ETF Trust | 1,03% | 110 401 NS | 30 de abril de 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,00% | 1 584 NS | 30 de abril de 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,96% | 1 504 470 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,82% | 707 389 SH | 8 de agosto de 2026 | Diario |
| ABFL · Abacus FCF ETF Trust | 0,80% | 20 613 NS | 30 de abril de 2026 | N-PORT |
| ROE · EA Series Trust | 0,79% | 10 387 NS | 29 de mayo de 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0,78% | 3 359 NS | 30 de abril de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,74% | 387 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,74% | 109 528 NS | 30 de abril de 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,73% | 3 833 NS | 30 de abril de 2026 | N-PORT |
| IWP · iShares Trust | 0,73% | 619 589 SH | 8 de agosto de 2026 | Diario |
| IXJ · iShares Trust | 0,70% | 122 846 SH | 8 de agosto de 2026 | Diario |
| LGDX · Tidal Trust III | 0,69% | 4 947 NS | 30 de abril de 2026 | N-PORT |
| RXL · ProShares Trust | 0,67% | 2 454 NS | 31 de mayo de 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,66% | 524 NS | 30 de abril de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,65% | 4 692 NS | 30 de abril de 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,58% | 38 214 NS | 30 de abril de 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,58% | 2 209 NS | 29 de mayo de 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,58% | 18 083 NS | 31 de mayo de 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0,56% | 2 763 NS | 31 de mayo de 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,54% | 5 075 476 SH | 8 de agosto de 2026 | Diario |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,52% | 4 667 NS | 30 de abril de 2026 | N-PORT |
| ITAN · EA Series Trust | 0,50% | 2 246 NS | 29 de mayo de 2026 | N-PORT |
| EVUS · iShares Trust | 0,49% | 7 746 SH | 8 de agosto de 2026 | Diario |
| KRMA · Global X Funds | 0,47% | 2 880 NS | 31 de mayo de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,47% | 18 983 SH | 8 de agosto de 2026 | Diario |
| JMID · Janus Detroit Street Trust | 0,45% | 423 NS | 30 de abril de 2026 | N-PORT |
| SFGV · EA Series Trust | 0,42% | 24 321 NS | 29 de mayo de 2026 | N-PORT |